
Sign up to save your podcasts
Or
Send us a text
In this Tech Tuesday episode, Ben and Daphna welcome Xina Quan, co-founder and CEO of PyrAmes, to introduce a groundbreaking neonatal device: the Boppli. Developed from Stanford research, the Boppli is a non-invasive, wearable blood pressure monitor that provides continuous, real-time readings—without the need for cuffs or arterial catheters.
FDA-cleared for babies under five kilograms, the Boppli uses a soft, adhesive-free band that wraps gently around an extremity. Backed by 3,400 hours of clinical validation, the Boppli has shown accuracy approaching that of invasive arterial lines according to the team at Pyrames.
Ben and Daphna explore how this innovation could reshape blood pressure monitoring for hypotensive and unstable neonates. Quan shares her vision of the Boppli becoming as commonplace as pulse oximetry in NICUs—empowering care teams with precise, painless data they can finally trust.
As she puts it, “Half the battle is having good data—this is a way to finally get it.”
As always, feel free to send us questions, comments, or suggestions to our email: [email protected]. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.
Enjoy!
4.9
142142 ratings
Send us a text
In this Tech Tuesday episode, Ben and Daphna welcome Xina Quan, co-founder and CEO of PyrAmes, to introduce a groundbreaking neonatal device: the Boppli. Developed from Stanford research, the Boppli is a non-invasive, wearable blood pressure monitor that provides continuous, real-time readings—without the need for cuffs or arterial catheters.
FDA-cleared for babies under five kilograms, the Boppli uses a soft, adhesive-free band that wraps gently around an extremity. Backed by 3,400 hours of clinical validation, the Boppli has shown accuracy approaching that of invasive arterial lines according to the team at Pyrames.
Ben and Daphna explore how this innovation could reshape blood pressure monitoring for hypotensive and unstable neonates. Quan shares her vision of the Boppli becoming as commonplace as pulse oximetry in NICUs—empowering care teams with precise, painless data they can finally trust.
As she puts it, “Half the battle is having good data—this is a way to finally get it.”
As always, feel free to send us questions, comments, or suggestions to our email: [email protected]. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.
Enjoy!
12,532 Listeners
2,419 Listeners
111,073 Listeners
55,861 Listeners
5,410 Listeners
228 Listeners
313 Listeners
126 Listeners
15,334 Listeners
4,343 Listeners
41,368 Listeners
320 Listeners
5 Listeners
274 Listeners
2 Listeners
2 Listeners
8 Listeners
0 Listeners
1,074 Listeners